Literature DB >> 8054982

Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q.

J A Terrett1, R Newbury-Ecob, G S Cross, I Fenton, J A Raeburn, I D Young, J D Brook.   

Abstract

Holt-Oram syndrome (HOS) is an autosomal dominant condition affecting the heart and upper limbs. We have sought to identify the location of this gene using microsatellite DNA markers in a linkage study. Of seven families analysed, five show linkage between HOS and markers on chromosome 12q. But the two remaining families, phenotypically indistinguishable from the others, do not show this linkage. Analysis with the computer program HOMOG indicates that HOS is a heterogeneous disease. Our analysis places one HOS locus in a 21 cM interval in the distal region of chromosome 12q. The localization of a gene for HOS, reported here, represents an important step towards a better understanding of limb and cardiac development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054982     DOI: 10.1038/ng0494-401

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  11 in total

1.  Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.

Authors:  Clémence Vanlerberghe; Anne-Sophie Jourdain; Jamal Ghoumid; Frédéric Frenois; Aurélie Mezel; Guy Vaksmann; Bruno Lenne; Bruno Delobel; Nicole Porchet; Valérie Cormier-Daire; Thomas Smol; Fabienne Escande; Sylvie Manouvrier-Hanu; Florence Petit
Journal:  Eur J Hum Genet       Date:  2018-12-14       Impact factor: 4.246

Review 2.  The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion.

Authors:  Laura E Briggs; Jayant Kakarla; Andy Wessels
Journal:  Differentiation       Date:  2012-06-17       Impact factor: 3.880

3.  Assignment of the developmentally regulated gene NEDD1 to human chromosome 12q22 by fluorescence in situ hybridization.

Authors:  S Takai; Y Yoshida; M Noda; K Yamada; S Kumar
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

4.  Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype.

Authors:  Anna-Marie E Brassington; Sandy S Sung; Reha M Toydemir; Trung Le; Amy D Roeder; Ann E Rutherford; Frank G Whitby; Lynn B Jorde; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2003-06-03       Impact factor: 11.025

5.  Restrictive and hypertrophic cardiomyopathies in Noonan syndrome: the overlap syndromes.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

6.  TBX5 intragenic duplication: a family with an atypical Holt-Oram syndrome phenotype.

Authors:  Chirag Patel; Lee Silcock; Dominic McMullan; Louise Brueton; Helen Cox
Journal:  Eur J Hum Genet       Date:  2012-02-15       Impact factor: 4.246

7.  Holt-Oram syndrome: a clinical genetic study.

Authors:  R A Newbury-Ecob; R Leanage; J A Raeburn; I D Young
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

8.  Diversity of congenital cardiac defects and skeletal deformities associated with the Holt-Oram syndrome.

Authors:  Gregory Chryssostomidis; Meletios Kanakis; Vassiliki Fotiadou; Cleo Laskari; Theofili Kousi; Christos Apostolidis; Prodromos Azariadis; Andrew Chatzis
Journal:  Int J Surg Case Rep       Date:  2014-05-09

Review 9.  Molecular genetics of congenital atrial septal defects.

Authors:  Maximilian G Posch; Andreas Perrot; Felix Berger; Cemil Ozcelik
Journal:  Clin Res Cardiol       Date:  2009-12-11       Impact factor: 5.460

Review 10.  Focused Strategies for Defining the Genetic Architecture of Congenital Heart Defects.

Authors:  Lisa J Martin; D Woodrow Benson
Journal:  Genes (Basel)       Date:  2021-05-28       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.